Navigation Links
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
Date:5/11/2012

/#!documentDetail;D=FDA-2011-D-0618-0025">http://www.regulations.gov/#!documentDetail;D=FDA-2011-D-0618-0025.  The deadline for submitting written comments following the hearing is May 25, 2012.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. 

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sa
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen to Present at the Baird Growth Stock Conference
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
4. Amgen Announces Webcast of 2012 First Quarter Financial Results
5. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
6. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
7. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
8. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
9. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
10. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
11. Amgen Announces Final Results of Its Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... SOUTH PLAINFIELD, N.J. , May 16, 2013 /PRNewswire/ ... a registration statement on Form S-1 with the U.S. ... initial public offering of its common stock. The number ... for the offering have not been determined. ... and Credit Suisse are acting as joint book-running managers ...
(Date:5/16/2013)... -- Alere Inc. (NYSE: ALR ), a global leader ... home through the merger of rapid diagnostics and health management, ... its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The ... record of Series B stock at the close of business ... the amount of all dividends accrued from April 1, 2013 ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... 2012 Hill-Rom Holdings, Inc., (NYSE: HRC ) ... Leerink Swann 2012 Global Healthcare Conference in New York City ... You are invited to listen to the live discussion via ... at http://wsw.com/webcast/leerink23/hrc/ .  A recorded replay of the discussion ...
... COPENHAGEN, Denmark, February 1, 2012 Pharmaceutical ... for electronic regulatory submissions services. Today, the company announced ... In this role, Mr. Kumar will contribute, together with ... for the life science industry, developing strategies and plans ...
Cached Medicine Technology:Shylendra Kumar Joins Pharmaceutical eConsulting 2
(Date:5/19/2013)... 19, 2013 The Da Vinci robot ... developments in the nation’s first trial involving a Da ... Washington State Superior Court, was filed by the widow ... suffered complications in a robot-assisted prostate removal, according to ... Vinci robotic surgery lawsuit alleges those complication’s hastened ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to ... John Colston, Daily Gossip’s spokesperson, told the press that the ... Rapid Fat Loss Plan . , Shaun Hadsall was ... a time when nutritionists and fat loss gurus constantly told ... The diet is based on the Macro-Patterning scheme, ...
(Date:5/18/2013)... 19, 2013) The American Gastroenterological Association (AGA) ... research scholars. This year,s honorees are outstanding young ... or related areas, and with this award, their ... young researchers are the future of our field. ... are paving the way for promising research developments ...
(Date:5/18/2013)... (PRWEB) May 19, 2013 Illuminations is proud ... Trisha Caetano. Seminars will take place over the course ... Friday, June 7, and Saturday, June 8, 2013. , Inner ... symptoms, but focuses on the attitudes, patterns and coping mechanisms ... symptoms. Participants will learn to live a more integrated and ...
(Date:5/18/2013)... Just a few extra cups of coffee each month ... disease known as primary sclerosing cholangitis (PSC), a new ... Rochester, Minn., found that drinking coffee was associated with ... lead to cirrhosis of the liver, liver failure and ... cause-and-effect relationship. "While rare, PSC has extremely ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2
... , Jan. 29 The Minnesota Medical Association Board ... to save the General Assistance Medical Care (GAMC) program, but not ... existing payments already do not cover the cost of providing care. ... would support health care programs. The MMA sent a letter to ...
... , LOS ANGELES , Jan. 29 In a ... the nation,s organ donation and transplant community will vote for the best ... Seven Pounds , Return to Me , John Q ... Philadelphia Transplant Movie Night, a group of transplant recipients, living donors and ...
... Project A.L.S. (New York, NY) and the Robert Packard ... MD) announced that they will partner on, P2 ALS, ... Gehrig,s disease) research exponentially over the next three years. ... leaders in forging productive collaborations among research scientists, will ...
... study finds , FRIDAY, Jan. 29 (HealthDay News) -- Genital ... that may help improve treatment and prevention, U.S. researchers say. ... seven separate genital sites in four women infected with herpes ... than one area on 56 percent of days when there ...
... , DALLAS , Jan. 29 ... charities from across the nation will be participants in its Medical ... Company has increased its giving by 23 percent in 2010, the ... million in transportation to 29 medical organizations who then provide ...
... CHARLOTTESVILLE, Va. , Jan. 29 Lodewijk J.R. ... industries, was elected to the Board of Directors of the Focused ... will serve a term of three years. , A founding partner ... Vink,s earlier executive positions included Chairman, International Health Care Partners; Chairman, ...
Cached Medicine News:Health News:Doctors Tell Lawmakers to Find a New GAMC Fix 2Health News:Nationwide Vote to Determine Best Organ Donation-Themed Movie 2Health News:Project A.L.S. and Packard Center take aim at ALS with $15 million program 2Health News:Southwest Airlines Announces Recipients of its 2010 Medical Transportation Grant Program 2Health News:Lodewijk de Vink Elected to Board of Focused Ultrasound Surgery Foundation 2Health News:Lodewijk de Vink Elected to Board of Focused Ultrasound Surgery Foundation 3
Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems...
Richardson Retractors...
... term being used today to describe the nature of ... may have been used in silicone implants in the ... not new technology cohesive is simply a word ... nature of the gel. All of Mentor silicone gel-filled ...
A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
Medicine Products: